Soleno Therapeutics (SLNO) Assets Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.73% |
| Dec 31, 2025 | 54.05% |
| Sep 30, 2025 | 52.90% |
| Jun 30, 2025 | 33.33% |
| Mar 31, 2025 | 58.19% |
| Dec 31, 2024 | 54.03% |
| Sep 30, 2024 | 59.52% |
| Jun 30, 2024 | 54.87% |
| Mar 31, 2024 | 34.15% |
| Dec 31, 2023 | 33.16% |
| Sep 30, 2023 | 15.56% |
| Jun 30, 2023 | -1.48% |
| Mar 31, 2023 | -11.67% |
| Dec 31, 2022 | -7.45% |
| Sep 30, 2022 | 3.92% |
| Jun 30, 2022 | 3.94% |
| Mar 31, 2022 | 4.67% |
| Dec 31, 2021 | 44.91% |
| Sep 30, 2021 | 38.64% |
| Jun 30, 2021 | 54.53% |
| Mar 31, 2021 | 43.28% |
| Dec 31, 2020 | 51.28% |
| Sep 30, 2020 | 58.01% |
| Jun 30, 2020 | 55.16% |
| Mar 31, 2020 | 26.11% |
| Dec 31, 2019 | 35.37% |
| Sep 30, 2019 | 76.10% |
| Dec 31, 2018 | 93.60% |